|
Re: Short interest updated to July 31st 842,419
|
3
|
Resverlogix Corp.
|
Aug 08, 2018 03:25PM
|
|
Re: Exempt Distribution - 2022-04-14
|
3
|
Resverlogix Corp.
|
Apr 18, 2022 08:56AM
|
|
January 2018 M&A.
|
3
|
Zenith Epigenetics
|
Jan 29, 2018 01:26PM
|
|
Re: Another IPO that shocks!
|
3
|
Zenith Epigenetics
|
Jan 18, 2021 07:35AM
|
|
Re: I'm hoping a SPAC will see Resverlogix and jump on it! Action by BOD needed
|
3
|
Resverlogix Corp.
|
Mar 03, 2021 09:30AM
|
|
Re: Bioasis announces intention of a non- brokered PP
|
3
|
BIOASIS TECHNOLOGIES INC
|
Jul 16, 2018 09:10AM
|
|
Re: Zenith Epigenetics is proud to announce the appointment Dr. Brad Thompson, PhD to our Board of Directors!
|
3
|
Zenith Epigenetics
|
Feb 16, 2022 07:36AM
|
|
Re: And we wait.....
|
3
|
Zenith Epigenetics
|
Jan 29, 2018 01:46PM
|
|
Re: This week could be very telling....
|
3
|
Resverlogix Corp.
|
Sep 25, 2016 07:55PM
|
|
Re: Merck's PIII Prostate trial, not the one with ZEN-3694, is halted for not showing improvement vs control
|
3
|
Zenith Epigenetics
|
Jan 26, 2023 11:26AM
|
|
Re: Also interesting, but less encouraging
|
3
|
Resverlogix Corp.
|
Aug 05, 2022 07:09AM
|
|
Re: The problem...as I see it
|
3
|
Resverlogix Corp.
|
Oct 20, 2020 09:58AM
|
|
Re: Phase 1b/2 trial expected to initiate 1Q 2019
|
3
|
Zenith Epigenetics
|
Mar 06, 2019 03:04PM
|
|
Re: BIO Investor Forum, Oct 22-23
|
3
|
Zenith Epigenetics
|
Oct 18, 2019 02:05PM
|
|
Re: So much for the little bit of momentum.....
|
3
|
Resverlogix Corp.
|
Apr 24, 2018 12:49PM
|
|
Re: Short interest creeps up again.....
|
3
|
Resverlogix Corp.
|
Apr 20, 2017 04:53PM
|
|
Re: Are BP doing their DD already on Apabetalone,..
|
3
|
Resverlogix Corp.
|
Feb 14, 2019 02:50PM
|
|
Re: Enthusiasm? NOT!
|
3
|
Zenith Epigenetics
|
Oct 28, 2021 03:48PM
|
|
Re: FDA meeting
|
3
|
Resverlogix Corp.
|
Aug 09, 2022 01:22PM
|
|
Re: Exempt Dist.
|
3
|
Zenith Epigenetics
|
Apr 16, 2021 05:41PM
|
